The growing use of copay accumulator programs, which restrict the application of patient assistance funds toward cost-sharing requirements, hurts patient access to life-changing treatments. This was one topic discussed during the ACR’s Advocacy Leadership Conference in D.C. this May.
![](https://www.the-rheumatologist.org/wp-content/uploads/2022/06/Donald-Miller-Photo-150x150.jpg)